Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.49 | 3e-58 |
mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.34 | 2e-29 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.32 | 2e-25 |
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.3 | 9e-21 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.4 | 1e-20 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.4 | 2e-16 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.38 | 2e-14 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-12 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-07 |